[{"会社名":"中外製薬(株)【4519】","証券コード":"4519","　":"前期","決算期":"2014年12月期","会計方式":"IFRS基準","決算発表日":"2015年1月28日","決算月数":"12か月","売上高":"461,109百万円","営業利益":"75,859百万円","経常利益":"76,164百万円","当期利益":"50,980百万円","EPS（一株当たり利益）":"93.53円","調整一株当たり利益":"93.38円","BPS（一株当たり純資産）":"1,092.90円","総資産":"739,538百万円","自己資本":"596,099百万円","資本金":"72,967百万円","有利子負債":"214百万円","自己資本比率":"80.6%","ROA（総資産利益率）":"7.10%","ROE（自己資本利益率）":"8.73%","総資産経常利益率":"10.60%"},{"会社名":"中外製薬(株)【4519】","証券コード":"4519","　":"2期前","決算期":"2013年12月期","会計方式":"IFRS基準","決算発表日":"2014年1月30日","決算月数":"12か月","売上高":"423,652百万円","営業利益":"78,738百万円","経常利益":"76,944百万円","当期利益":"50,895百万円","EPS（一株当たり利益）":"93.47円","調整一株当たり利益":"93.35円","BPS（一株当たり純資産）":"1,049.47円","総資産":"697,212百万円","自己資本":"571,692百万円","資本金":"72,967百万円","有利子負債":"233百万円","自己資本比率":"82.0%","ROA（総資産利益率）":"7.92%","ROE（自己資本利益率）":"9.61%","総資産経常利益率":"11.98%"},{"会社名":"中外製薬(株)【4519】","証券コード":"4519","　":"3期前","決算期":"2012年12月期","会計方式":"日本方式","決算発表日":"2013年1月30日","決算月数":"12か月","売上高":"391,220百万円","営業利益":"76,413百万円","経常利益":"75,406百万円","当期利益":"48,205百万円","EPS（一株当たり利益）":"88.58円","調整一株当たり利益":"88.54円","BPS（一株当たり純資産）":"896.02円","総資産":"587,720百万円","自己資本":"487,653百万円","資本金":"72,966百万円","有利子負債":"---","自己資本比率":"83.0%","ROA（総資産利益率）":"8.60%","ROE（自己資本利益率）":"10.21%","総資産経常利益率":"13.45%"}]